Prostatype – a modern genetic test

Our background

The Prostatype test is the result of 20 years of research and experience in the field of prostate cancer at Karolinska Institutet. Since the start in 2007, the company has had a clear goal; to improve the care and care of prostate cancer patients and make a difference for the individual. The test provides a more reliable answer to the question of whether treatment is required or not, and is an important complement to other samples. It can counteract overdiagnosis, prevent patients from suffering from annoying side effects unnecessarily and increase the quality of life for affected men.

Facts: prostate cancer and genetic testing

  • Prostate cancer is Sweden’s most common form of cancer with about 100,000 affected right now. Despite the large number of victims, there are in many cases uncertainties about whether treatment is necessary or not, which leads to overtreatment.
  • Genetic testing for various cancers such as prostate cancer and breast cancer is on the rise. In the United States, prognostic genetic tests are recommended for prostate cancer patients at low risk and are covered by health insurance. In Germany, it is discussed that genetic testing for breast cancer should be covered by health insurance.
  • Prostate type is the first genetic test of its kind in Sweden that can supplement investigations of prostate cancer. Read about how the test works.

Our background

The Prostatype test is the result of 20 years of research and experience in the field of prostate cancer at Karolinska Institutet. Since the start in 2007, the company has had a clear goal; to improve the care and care of prostate cancer patients and make a difference for the individual. The test provides a more reliable answer to the question of whether treatment is required or not, and is an important complement to other samples. It can counteract overdiagnosis, prevent patients from suffering from annoying side effects unnecessarily and increase the quality of life for affected men.

Facts: prostate cancer and genetic testing

  • Prostate cancer is Sweden’s most common form of cancer with about 100,000 affected right now. Despite the large number of victims, there are in many cases uncertainties about whether treatment is necessary or not, which leads to overtreatment.
  • Genetic testing for various cancers such as prostate cancer and breast cancer is on the rise. In the United States, prognostic genetic tests are recommended for prostate cancer patients at low risk and are covered by health insurance. In Germany, it is discussed that genetic testing for breast cancer should be covered by health insurance.
  • Prostate type is the first genetic test of its kind in Sweden that can supplement investigations of prostate cancer. Read about how the test works.

I want to be contacted

Do you have questions about Prostatype? We answer your questions and thoughts.

Kontakt Engelsk

Or call  +46(0)8-20 87 00